Maine Cannabis Market Stats

Headline Numbers — Calendar Year 2025

Primary sources: OCP Adult Use Cannabis Program 2025 Annual Report (28-B M.R.S. §113); OCP Medical Use of Cannabis Program 2025 Annual Report (22 M.R.S. §2430-N); mainecannabis.org monthly Maine Revenue Services sales reports; Marijuana Herald reporting from OCP data releases (Jan & Jul 2026).

Adult-Use Sales, 2020 – H1 2026 — A Five-Year Arc

Adult-use (recreational) cannabis sales launched in Maine on October 9, 2020. The first five full calendar years of the program show three distinct phases: launch ramp (2021), double-digit growth (2022–2024), and maturation/plateau (2025). The 2026 half-year data continues the plateau.

Sources: $246.4M / 4,835,678 transactions / $6.62 avg price for CY2025 — Marijuana Herald (Jan 2026) reporting OCP data release. H1 2026 $119,954,243 / 2,439,812 transactions / $6.10 avg price — Marijuana Herald (July 2026). 2020–2024 figures — mainecannabis.org monthly aggregation of Maine Revenue Services adult-use-cannabis taxable sales, reconciled to OCP annual reports. Note: 2025 figure is OCP-released; the 2020–2024 series is reported as MRS-adult-use-sales (a narrower tax-base than the OCP total but consistent under the same reporting regime).

What the five-year curve tells us

• The launch ramp (2021) added $77.6M in year-one sales — a 19x jump off the $4.35M partial-year 2020 base. This is the period when supply, consumer awareness, and store count were all ramping together.
• Growth years (2022–2024) added $161.9M in cumulative incremental sales — roughly $54M of growth per year, driven by new store openings and price normalization.
• The plateau (2025) added only $2.5M over 2024. But: average price fell $0.63/gram (8.6%), implying that the physical units sold grew faster than dollar revenue. Per the Marijuana Herald December 2025 readout, unit volume in December 2025 alone was 388,831 transactions — consistent with steady volume growth on a price-deflated basis.
• H1 2026 numbers ($119.95M, 2.44M transactions, $6.10/g YTD) are consistent with an annualized total of $244–248M for full-year 2026 — i.e., another plateau year. There is no evidence in the H1 data of a Q2 acceleration that would project back to a 2026 total above $250M.

Active Licensed Establishments by Type

Adult-use cannabis licensing in Maine occurs at four tiers under 28-B M.R.S. §207. Total active adult-use establishment counts crossed 300 in 2023 and have been growing at low single-digit rates since.

Source: OCP Adult Use Cannabis Program 2024 + 2025 Annual Reports (28-B M.R.S. §113). Note the difference between active (currently licensed) and operating (currently open and selling) — Maine's licensed-but-not-yet-operating gap is usually 5–15% of the active total. The cross-program contrast is sharp: adult-use retailer counts are flat, while medical dispensary counts (see below) grew 28.5% in 2025.

Medical Program, 2021 – 2025

The Maine Medical Use of Cannabis Program (MMCP) is the older of the two regulated cannabis markets and behaves counter-cyclically to adult-use. As adult-use plateaued in 2025, medical patient certifications, medical providers, and registered dispensaries all grew — while the caregiver population continued its multi-year decline.

Source: OCP Medical Use of Cannabis Program 2025 Annual Report (Feb 13, 2026) reporting on 22 M.R.S. §2430-N requirements. Patient-certification counts include reprints (per OCP methodology); "registrant-related employment" series starts at 4,358 in 2024 because the registry identification card (RIC) two-year-cycle reform took effect July 1, 2024.

What the medical numbers show

• Dispensaries grew fastest. Registered medical dispensaries grew from 35 (2022) → 60 (2023) → 70 (2024) → 90 (2025), a 28.5% YoY expansion in 2025 alone — and 46 → 62 retail locations, +34.7% YoY. The 2025 expansion was fueled by caregivers who transitioned to formal dispensary status after the January 2021 dispensary-cap expiration and the PL 2023 c. 365 framework.
• Patient volume is steady, not surging. Certifications grew 1.8% YoY in 2025 — slower than 2024 (+1.4%) but still positive. Compare this to the mature, flat-to-declining patient-count patterns in mature markets like Colorado or Oregon.
• The caregiver population is shrinking. 1,539 active caregivers at year-end 2025 vs 1,677 in 2024 (−8.2%) — the seventh consecutive year of decline since the 2021 peak of 3,257. The caregiver exodus reflects PL 2023 c. 365 + PL 2023 c. 679 framework tightening, plus caregiver-to-dispensary transitions.
• Provider count continues to climb. 808 active certifying providers in 2025 vs 777 in 2024 — a 3.9% increase, smaller than prior years. Providers remain concentrated: the top 10 (out of 808) issued 83,636 of 112,547 certifications (74.3% of all printed certifications statewide in 2025).

Regional & County Breakdown

Maine's adult-use cannabis sales are highly geographically concentrated. The OCP's Analytics Director, Eric Miller, told the Joint Standing Committee on Veterans and Legal Affairs at the 5th-anniversary briefing on October 10, 2025 that "York and Cumberland counties combined account for nearly 60 percent of all retail sales." (Maine Public; Portland Press Herald; Sun Journal.) This concentration tracks population density, tourism traffic, and the licensed-retailer footprint, but also reflects cross-border demand from New Hampshire and Massachusetts residents who can drive into Maine for legal adult-use cannabis purchases.

Sources: County share estimates — Eric Miller, OCP Analytics Director, VLA Committee briefing (Oct 10, 2025), reported by Maine Public / Press Herald / Sun Journal. Modeled Store-license IDs — MDG retail-density model anchored to the OCP canonical June 1, 2026 active Store-license snapshot (187 distinct identities statewide), not the 2025 Annual Report’s 180 retail stores or the July 8, 2026 live storefront roster. Estimated sales = state total × county share % (CY2025 base $246.4M). The "60% in two counties" figure is OCP-stated; the per-county split shown above is a modeling estimate cross-referenced against retail-density heat-mapping and may sum to 99% due to rounding.

County-level visual (modeled Store-license identities)

Municipal opt-in vs active footprint

The OCP's dated live licensee-search roster identifies active adult-use Store entries in 50 municipalities as of 2026-07-08. That is a storefront footprint, not a statewide opt-in count: a municipality may authorize retail without a current Store entry, and licensing records may use mailing and host-municipality information differently. Use the MDG 2026 Opt-In Tracker and verify local rules with the town clerk before relying on a municipal status.

Tax Revenue Trajectory, 2020 – 2025

Maine raises cannabis tax revenue from two streams: (1) AUCP fees and excise collected by the Office of Cannabis Policy, deposited via the State Controller to the General Fund with retention for OCP regulatory operations; and (2) the 5.5% general state sales tax on medical cannabis (8% on edible cannabis products as prepared food), collected by Maine Revenue Services and deposited in the General Fund. Both streams are reported annually; the figures below combine both.

Sources: AUCP revenue 2020–2025 ($1.55M / $13.47M / $28.75M / $35.18M / $40.73M / $43.72M) — mainecannabis.org reporting OCP annual reports. Note this is total AUCP receipts (excise + license + registration fees), not the narrower General-Fund-only portion. Medical sales tax ($15.06M FY2024; $14.28M FY2025) — OCP MMCP 2025 Annual Report §6, sourced from Maine Revenue Services (MRS).

Reading the numbers

• AUCP growth has decelerated. YoY AUCP revenue growth ran 770% (2020→21), 113% (2022), 22% (2023), 16% (2024), and 7% (2025). This mirrors the underlying sales plateau — fixed-fee revenue (license, registration) grows with operator count, while excise-pools-volume grows with sales.
• Medical sales tax to GF declined. $15.06M (FY2024) → $14.28M (FY2025), a 5.2% YoY decline. Counter-intuitive given patient-certification growth, but consistent with caregiver-channel sales still going tax-exempt on the caregiver-to-patient transfer.
• January 1, 2026 reset. The biennial budget (P.L. 2025, ch. 388) restructured these effective Jan 1, 2026 — see the next section for the line-by-line changes.

Product Mix (December 2025 Snapshot)

OCP reports adult-use sales split into three product categories. December 2025 — a representative month — provides the cleanest per-category breakdown in the public data.

Sources: OCP data release reported by Marijuana Herald on January 13, 2026. The "infused products" category aggregates edibles, beverages, topicals, and other infused SKUs as reported by OCP. National context: flower + pre-rolls were the only dollar-share-gaining major categories nationally in 2025 (BDSA, 2026 State of the Cannabis Industry); beverages grew +15% YoY in Q1 2025 nationally (BDSA), and the share-of-edibles-and-beverages share of total Maine spend is consistent with the BDSA national mix.

January 1, 2026 Tax Reset

The biennial budget passed by the 131st Legislature and signed by Governor Mills (P.L. 2025, ch. 388) restructured Maine cannabis taxes effective January 1, 2026. The directional change: lower cultivation excise (30–43% reductions) financed by a higher retail sales tax (10.0% → 14.0%). Medical patients continue to pay only the 5.5% state sales tax on harvested cannabis, unchanged.

Source: Maine Morning Star (December 31, 2025) reporting the biennial budget; Maine Department of Administrative and Financial Services fiscal note; cross-checked against the Federation of Tax Administrators State Taxation and Sales of Recreational Marijuana tracker. The fiscal-note estimate: $15.4M in additional two-year sales-tax revenue (~$5.2M annualized), partially offset by $10.2M in lost two-year excise revenue (~$5.1M annualized). Net biennial revenue impact: ~$5.2M positive to the General Fund.

What this means in practice

• For consumers: A gram that retailed at $6.62 in December 2025 retails at roughly $6.86 in 2026 (4.0 pp × pretax price / 1.10) — a 3.6% effective shelf-price increase, unless operators absorb the sales-tax difference to keep shelf prices flat.
• For cultivators: Excise tax per pound on flower drops from $335 to $223 — a 33.4% reduction. For a cultivator moving 100 lb/month, that is $11,200/month in saved excise (annualized ~$134,400).
• For processors: Trim excise drops 33.0%; mature plants 34.3%; immature plants 33.3%; seeds 42.9%. Across a typical product mix, the per-pound effective rate drops roughly a third — meaningful relief for vertically integrated operators who carry the excise on their own wholesale-to-retail handoff.
• For medical patients: No change. Patients continue to pay only the 5.5% state sales tax on harvested cannabis, with the 8% rate on edible cannabis products (classified as prepared food), unchanged. The MMCP 2025 Annual Report (§6) attributes the 5.2% YoY decline in medical sales tax revenue to a reweighting of sales channels toward caregiver-to-patient transfers (which are tax-exempt), not to a sales decline.

2026 Trends & Outlook

1. The plateau is the new normal

Maine's adult-use market is no longer in a growth-at-all-costs phase. Total 2026 sales are projected at $244–248M (H1 2026 actual + OCP reporting cadence) — within 1% of 2025. The pricing story tells the real story: average flower price has fallen from $11.85/gram (2021) to $6.62/gram (2025) and now to $6.10/gram YTD in 2026 — a 48.5% five-year decline on the most-purchased SKU. Operators have absorbed both price compression AND the Jan 1, 2026 sales-tax uplift. The survivor is the operator with a tight cost structure and a loyal patient/consumer base; the loser is anyone who grew on the assumption of continued double-digit top-line growth.

2. Consolidation is accelerating

Adult-use retail storefronts have been flat (180 active at year-end 2025); the OCP live roster shows 106 active entries as of 2026-07-08. MJBizDaily, Cannabismarketcap, and the Cannabusinessplans Maine-market report all describe the national 2026 picture as "consolidation, maturation, and a pivot from growth-at-all-costs to sustainable profitability." Maine-specific consolidations: multi-store operators absorbing single-location ones, branded cultivation networks acquiring independent grows, and a small but real wave of opt-out operators shutting down. The market-pulse-2026 page's M&A tracker captures the public transactions; the Maine market analysis guide gives the operator-facing context.

3. The Jan 1, 2026 tax restructure cuts two ways

The 14.0% retail sales tax (up from 10.0%) is a ~3.6% effective shelf-price uplift — modest, but on top of continued wholesale flower-price compression it tightens retail margins further. The 33.4% cultivation excise cut (flower $335 → $223/lb) returns some margin to growers and vertically integrated retailers. Net effect: a slight rebalancing from retail margin to wholesale margin, with Maine's smallest standalone dispensaries (those most exposed to retail-margin compression) the most at risk. For per-store modeling, the ROI calculator accepts the new tax rates; the tax calculator shows effective-rate math at any gross-revenue level.

4. April 2026: testing-reform relief

P.L. 2025, ch. 764 (emergency effective April 19, 2026) eliminates mandatory contaminant testing for adult-use edible products manufactured from concentrate that has already passed the required contaminant panel. Edibles still require THC-potency, cannabinoid-content, and homogeneity testing. This is a meaningful manufacturing-friction reduction for processors in the edibles-and-beverages category — a segment BDSA projects at +14.6% CAGR nationally through 2031.

5. The medical program is the structural counterweight

While adult-use plateaued, medical dispensaries grew 28.5% YoY in 2025 (70 → 90), medical retail locations grew 34.7% YoY (46 → 62), and medical employees grew 21.4% YoY (4,358 → 5,291). Patient certifications remain the soft metric (+1.8% YoY in 2025 vs +1.4% in 2024). The discrepancy — fast store-front growth on slow patient-certification growth — suggests the medical-channel expansion is being driven by caregiver-to-dispensary transitions and new-product-format adoption among existing patients, not by a surge of new patients. The OCP itself recommends (in the MMCP 2025 Annual Report §7.2) the Legislature establish mandatory contaminant testing and inventory tracking in the medical program "to ensure patient health and safety," a recommendation that has been carried over in successive sessions and remains OCP's top legislative ask.

6. Outlook: dollars flat, transactions slightly up, active operator count slightly down

The 2026 picture is consistent with the 2025 plateau: total dollars essentially flat ($244–248M annualized), total transactions up modestly (+3–5% YoY), and active operator count down (~10–15 stores closed or license-lapsed net of new openings through year-end). The state's bid to consolidate the caregiver gray market into the regulated dispensary channel (via continued dispensary-cap expiration effects and caregiver-to-dispensary transitions) is the structural offset: it keeps supply-chain-side activity elevated while AU-side dollar revenue stays flat. For operators, planning on continued growth at this point is planning on a different market than the one the data describes.

National & Federal Context — How Maine Compares

Maine's $246.4M adult-use market is meaningful in-state but small in the national picture. This section places Maine in the broader US context: market size, jobs, tax burden, federal regulatory status, retail pricing benchmarks, and where Maine sits relative to New England + comparable legal states. Every figure here cites a primary federal or trade-press source; the source pack at docs/research/market-stats-national-source-pack-2026-07-09.md carries the full citation trail and 5 documented caveats (Statista paywall, FBI UCR floor effect, DEA scheduling three-tier split, NSDUH 2021+ multimode break, Headset 12-market extrapolation).

Primary sources: Statista 2026 cannabis market outlook (cited via Flowhub, paywalled at source); SAMHSA NSDUH 2024 (HHS Pub PEP25-07-007, released Aug 6, 2025); NCSL State Medical Cannabis Laws tracker + State Cannabis Regulation tracker (June 26, 2025); Vangst 2025 Jobs Report (per Flowhub); Headset retail POS data (June 2026); Whitney Economics federal-tax-impact brief (April 9, 2026).

National market size, jobs, and tax burden

Sources: U.S. 2026E ($47B) — Statista cannabis market outlook (free page is paywalled; figure cited via Flowhub 2026, accessed 2026-07-09). U.S. 2030E ($55.4B at 3.36% CAGR) — Statista, same citation trail. U.S. 2024 actual ($30.1B) — Whitney Economics + BDSA consensus. 2025 actuals diverge: BDSA back-cast $31.5B ($23.9B AU + $7.6B medical, per Flowhub); Whitney revised its 2025 forecast DOWN to $29.1–29.6B in December 2025, marking the first-ever annual YoY decline in U.S. legal cannabis revenue. Jobs data: Vangst 2025 Jobs Report counts 425,002 direct FTE jobs (down 3.4% YoY); Leafly+Whitney 2026 (cited via cannabispromotions.com) counts 445,800 FTE jobs (up 1.2% YoY, includes ancillary). The discrepancy is methodology, not contradiction: Vangst = direct cannabis; Leafly+Whitney = direct + ancillary. Tax burden: Whitney Economics' April 9, 2026 brief estimates cannabis businesses paid $2.24B in excess federal tax due to 280E in 2025 alone; $27B cumulative federal tax since 2018, of which $15B is excess 280E tax. The IRS Statistics of Income division does NOT publish a 280E-specific line in its public data products — Whitney is the de facto citation standard for this metric.

How Maine's price compares to other legal states

Pricing data caveats: The Headset June 2026 figures ($8.94/g single-gram, $3.62/g equivalized) are the cleanest direct national comparison and come from a 12-market retail-POS panel (not all 24 adult-use states). The previously-cited $8.92/g national average (in earlier versions of this page) traces to Cannabis Benchmarks 2025 via Cannabis Promotions (an aggregator); Headset's $8.94 is the same data point with a one-step-fresher primary trail. State-specific prices: Michigan at $3.80/g (cheapest) and Illinois at $15.80/g (most expensive) per Cannabis Promotions 2025. The Maine OCP-weighted $6.62/g sits 26% below the $8.94 single-gram national average and 83% above the $3.62 equivalized average — the gap reflects Maine's heavier weighting toward bulk-gram sales (where wholesale-to-retail margins are tighter than on eighths or ounces). Headset's June 2026 eighth spread runs $11.55 (Oregon) to $31.11 (Ohio) — a 2.7x cross-state range.

Where Maine sits among the 24 adult-use states

Federal regulatory status — three-tier transitional

Sources: DEA marijuana rescheduling page (dea.gov/marijuana-rescheduling-regulatory-actions); Federal Register notice of hearing (91 FR 22777, April 28, 2026); Federal Register final rule placing state-licensed medical marijuana in Schedule III (91 FR doc 2026-08176, effective April 22, 2026); 2018 Farm Bill §10113 (7 U.S.C. §1639o); 2026 Appropriations Act §781 (changing the federal hemp definition to a total-THC standard with 0.4 mg/container cap effective November 12, 2026, contested by H.R. 7024 / H.R. 7010 / Senate delay bills). The DEA ALJ hearing on the broader Schedule I → III rescheduling NPRM concluded Jul 15, 2026; post-hearing briefs due Aug 17, 2026; ALJ has no deadline; DEA Administrator final rule has no deadline. Adult-use cannabis remains Schedule I at the federal level — 21 U.S.C. §812; 21 CFR §1308.11.

Federal marijuana arrests — the post-legalization trend

Sources: NORML press release (Sept 25, 2024) analyzing FBI Crime Data Explorer data. The 217,150 figure for 2023 represents a floor, not a ceiling: in 2022, 17% of agencies (representing 25% of the US population) failed to report to the FBI. The 2007 peak (870,000+ arrests, ~48% of all drug arrests) and the 2021 FBI methodology change mean pre-2021 vs post-2021 data is not directly comparable. The trend across 2007–2023 (870K → 217K, −75%) is the cleanest read of the post-legalization effect: a meaningful national decline in marijuana-related arrests, even as the drug has been legalized in 24 states.

Where this leaves Maine in the national picture

• Market position. Maine is a mature, plateau-state by national 2026 standards — adult-use growth has flattened at ~1% YoY while mature states (Colorado, California, Oregon) are now showing YoY declines. Maine's 2026 projected $244–248M is within 1% of 2025, consistent with the national "growth by geography, plateau by maturity" pattern documented by Whitney Economics (December 2025).
• Price position. Maine flower at $6.62/g (OCP-weighted) is 26% below the $8.94 single-gram national average (Headset June 2026) — cheap for an East Coast state, comparable to West Coast mature markets, more expensive than the $3.62 equivalized national average (which weights toward bulk-gram and ounce packages).
• Federal exposure. Maine's 24 adult-use stores + 90 medical dispensaries are split between Schedule III (medical) and Schedule I (adult-use) at the federal level as of July 9, 2026. The DEA ALJ hearing concluded Jul 15, 2026; post-hearing briefs due Aug 17, 2026; outcome pending as of page publish date. Maine operators should plan for both outcomes and consider medical/adult-use P&L segregation as a defensive practice.
• Operator economics. National cannabis-supported FTE jobs declined 3.4% YoY in 2025 (Vangst), the first YoY employment decline since legal markets began — a parallel signal to the 2025 revenue decline. Maine's own data shows a similar pattern: adult-use store count flat at 180, OCP roster tightening. The labor-market signal confirms the maturation read.
• For consumer guides: if you're a shopper, the cannabis terpenes & effects guide covers what to look for; the tinctures guide covers lower-risk entry formats; the edible dose calculator helps with the most common 280E-irrelevant consumer math problem (over-consumption).
• For operators: if you're modeling a new license, the ROI calculator uses national and Maine benchmarks to project per-store economics; the tax calculator handles the Jan 1, 2026 tax reset; the Maine market analysis guide gives the operator-facing context; the license requirements guide walks the application step-by-step.
• For municipal / investor readers: the market pulse 2026 page tracks quarterly license activity, opt-in coverage, and M&A events — the companion dataset to this page for people who want the operator-footprint story.